Overview

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2018-01-31
Target enrollment:
Participant gender:
Summary
A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Metformin
Rosuvastatin Calcium